239 related articles for article (PubMed ID: 20068069)
1. Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells.
Zoubeidi A; Ettinger S; Beraldi E; Hadaschik B; Zardan A; Klomp LW; Nelson CC; Rennie PS; Gleave ME
Mol Cancer Res; 2010 Jan; 8(1):119-30. PubMed ID: 20068069
[TBL] [Abstract][Full Text] [Related]
2. Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression.
Wang Y; Wang X; Zhao H; Liang B; Du Q
J Chemother; 2012 Dec; 24(6):348-57. PubMed ID: 23174100
[TBL] [Abstract][Full Text] [Related]
3. Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy.
Sowery RD; Hadaschik BA; So AI; Zoubeidi A; Fazli L; Hurtado-Coll A; Gleave ME
BJU Int; 2008 Aug; 102(3):389-97. PubMed ID: 18336596
[TBL] [Abstract][Full Text] [Related]
4. Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex.
Trougakos IP; Lourda M; Antonelou MH; Kletsas D; Gorgoulis VG; Papassideri IS; Zou Y; Margaritis LH; Boothman DA; Gonos ES
Clin Cancer Res; 2009 Jan; 15(1):48-59. PubMed ID: 19118032
[TBL] [Abstract][Full Text] [Related]
5. The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degradation of UXT isoform 2 (UXT-V2) to inhibit the NF-κB signaling pathway.
Spagnol V; Oliveira CAB; Randle SJ; Passos PMS; Correia CRSTB; Simaroli NB; Oliveira JS; Mevissen TET; Medeiros AC; Gomes MD; Komander D; Laman H; Teixeira FR
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129754. PubMed ID: 33010352
[TBL] [Abstract][Full Text] [Related]
6. COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase.
Maine GN; Mao X; Komarck CM; Burstein E
EMBO J; 2007 Jan; 26(2):436-47. PubMed ID: 17183367
[TBL] [Abstract][Full Text] [Related]
7. PDLIM7 Synergizes With PDLIM2 and p62/Sqstm1 to Inhibit Inflammatory Signaling by Promoting Degradation of the p65 Subunit of NF-κB.
Jodo A; Shibazaki A; Onuma A; Kaisho T; Tanaka T
Front Immunol; 2020; 11():1559. PubMed ID: 32849529
[TBL] [Abstract][Full Text] [Related]
8. Targeting the cytoprotective chaperone, clusterin, for treatment of advanced cancer.
Zoubeidi A; Chi K; Gleave M
Clin Cancer Res; 2010 Feb; 16(4):1088-93. PubMed ID: 20145158
[TBL] [Abstract][Full Text] [Related]
9. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
Shukla S; Gupta S
Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
[TBL] [Abstract][Full Text] [Related]
10. PIDD mediates NF-kappaB activation in response to DNA damage.
Janssens S; Tinel A; Lippens S; Tschopp J
Cell; 2005 Dec; 123(6):1079-92. PubMed ID: 16360037
[TBL] [Abstract][Full Text] [Related]
11. HSCARG regulates NF-kappaB activation by promoting the ubiquitination of RelA or COMMD1.
Lian M; Zheng X
J Biol Chem; 2009 Jul; 284(27):17998-8006. PubMed ID: 19433587
[TBL] [Abstract][Full Text] [Related]
12. mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer.
Bhutia SK; Das SK; Kegelman TP; Azab B; Dash R; Su ZZ; Wang XY; Rizzi F; Bettuzzi S; Lee SG; Dent P; Grant S; Curiel DT; Sarkar D; Fisher PB
J Cell Physiol; 2012 May; 227(5):1805-13. PubMed ID: 21732348
[TBL] [Abstract][Full Text] [Related]
13. Identification of clusterin domain involved in NF-kappaB pathway regulation.
Essabbani A; Margottin-Goguet F; Chiocchia G
J Biol Chem; 2010 Feb; 285(7):4273-7. PubMed ID: 20028970
[TBL] [Abstract][Full Text] [Related]
14. Nucleolar targeting of RelA(p65) is regulated by COMMD1-dependent ubiquitination.
Thoms HC; Loveridge CJ; Simpson J; Clipson A; Reinhardt K; Dunlop MG; Stark LA
Cancer Res; 2010 Jan; 70(1):139-49. PubMed ID: 20048074
[TBL] [Abstract][Full Text] [Related]
15. The ubiquitin ligase HERC3 attenuates NF-κB-dependent transcription independently of its enzymatic activity by delivering the RelA subunit for degradation.
Hochrainer K; Pejanovic N; Olaseun VA; Zhang S; Iadecola C; Anrather J
Nucleic Acids Res; 2015 Nov; 43(20):9889-904. PubMed ID: 26476452
[TBL] [Abstract][Full Text] [Related]
16. Non-secreted clusterin isoforms are translated in rare amounts from distinct human mRNA variants and do not affect Bax-mediated apoptosis or the NF-κB signaling pathway.
Prochnow H; Gollan R; Rohne P; Hassemer M; Koch-Brandt C; Baiersdörfer M
PLoS One; 2013; 8(9):e75303. PubMed ID: 24073260
[TBL] [Abstract][Full Text] [Related]
17. Secreted clusterin gene silencing enhances chemosensitivity of a549 cells to cisplatin through AKT and ERK1/2 pathways in vitro.
Zhang B; Zhang K; Liu Z; Hao F; Wang M; Li X; Yin Z; Liang H
Cell Physiol Biochem; 2014; 33(4):1162-75. PubMed ID: 24751980
[TBL] [Abstract][Full Text] [Related]
18. Clusterin and chemoresistance.
Djeu JY; Wei S
Adv Cancer Res; 2009; 105():77-92. PubMed ID: 19879424
[TBL] [Abstract][Full Text] [Related]
19. Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells.
Zhong B; Sallman DA; Gilvary DL; Pernazza D; Sahakian E; Fritz D; Cheng JQ; Trougakos I; Wei S; Djeu JY
Mol Cancer Ther; 2010 Jun; 9(6):1831-41. PubMed ID: 20501799
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of NF-kappaB-dependent Bcl-xL expression by clusterin promotes albumin-induced tubular cell apoptosis.
Takase O; Minto AW; Puri TS; Cunningham PN; Jacob A; Hayashi M; Quigg RJ
Kidney Int; 2008 Mar; 73(5):567-77. PubMed ID: 18075502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
